multipl
organ
failur
vascular
hyperperm
common
caus
death
sever
season
highli
pathogen
influenza
viru
infect
condit
usual
associ
hypercytokinemia
sever
edema
lung
heart
liver
kidney
brain
previou
studi
propos
hypothesi
cycl
one
key
mechan
vascular
hyperperm
multipl
organ
failur
sever
influenza
process
influenza
viru
entri
cell
proteolyt
convers
viral
envelop
fusion
glycoprotein
hemagglutinin
subunit
host
cellular
trypsintyp
proteas
prerequisit
membran
fusion
activ
haprocess
proteas
encod
viral
genom
viral
infect
ensu
ectop
pancreat
trypsin
one
cellular
haprocess
proteas
express
limit
amount
variou
organ
lung
heart
brain
markedli
upregul
induct
proinflammatori
cytokin
upregul
trypsin
potenti
viral
multipl
variou
organ
lead
cellular
dysfunct
vascular
hyperperm
fluid
imbal
proteinaseactiv
tissu
damag
involv
matrix
metalloproteas
mmp
trypsin
also
report
crucial
infect
virus
rotavirus
member
famili
reovirida
coronavirus
member
famili
coronavirida
addit
influenza
viru
member
famili
orthomyxovirida
sendai
viru
newcastl
diseas
viru
member
famili
paramyxovirida
proinflammatori
cytokin
tumor
necrosi
factor
increas
infect
organ
blood
hypercytokinemia
consid
host
defens
respons
influenza
viru
infect
presenc
high
level
proinflammatori
cytokin
howev
impair
energi
metabol
mitochondria
lead
cellular
dysfunct
organ
failur
although
report
previou
vivo
vitro
studi
proinflammatori
cytokin
trigger
trypsin
upregul
cycl
still
clear
whether
key
cytokin
affect
trypsin
upregul
follow
cascad
multipl
organ
failur
sever
influenza
effect
challeng
individu
multipl
proinflammatori
cytokin
inflammatori
respons
variou
organ
report
mice
rat
also
variou
cell
line
studi
highlight
interact
contribut
diseas
progress
howev
littl
inform
avail
cytokin
crosstalk
trypsin
upregul
aim
present
studi
determin
presenc
proinflammatori
cytokin
crosstalk
effect
trypsin
upregul
particularli
lung
initi
site
influenza
viru
replic
addit
anim
studi
also
use
cell
human
type
ii
lung
epitheli
cell
line
confirm
result
anim
experi
cell
line
suitabl
experi
cell
constitut
express
receptor
releas
natur
inhibitor
specif
pathogenfre
femal
mice
purchas
slc
saitama
japan
mice
treat
accord
guid
care
use
laboratori
anim
nih
public
studi
approv
anim
care
committe
tokushima
univers
influenza
viru
apuerto
kindli
provid
research
foundat
microbi
diseas
osaka
univers
kagawa
japan
ketamin
xylazin
anesthesia
plaqueform
unit
pfu
salin
salin
alon
noninfect
control
instil
intranas
mice
cytokin
administr
experi
mice
treat
intraperiton
inject
singl
cytokin
combin
cytokin
twice
day
three
day
cytokin
use
treatment
mous
recombin
r
system
minneapoli
mn
dose
per
day
dose
within
rang
cytokin
found
lung
pfu
infect
also
within
dose
recommend
previou
studi
mice
monitor
daili
bodi
weight
surviv
rate
euthan
day
postinfect
lung
extract
measur
level
cytokin
trypsin
assess
patholog
role
multipl
organ
failur
antimous
goat
polyclon
antibodi
r
system
neutral
purifi
mous
igg
normal
mice
wako
pure
chemic
industri
ltd
osaka
japan
mgml
salin
vehicl
administ
intraperiton
mice
treatment
hour
pfu
salin
salin
alon
instil
intranas
mice
euthan
day
postinfect
lung
process
histopatholog
evalu
lung
perfus
ml
salin
right
atrium
heart
fix
buffer
formalin
ph
isol
embed
paraffin
paraffin
block
crosssect
thick
use
microtom
leica
hematoxylin
eosin
stain
done
subsequ
imag
acquir
microscop
keyenc
corpor
osaka
japan
analyz
imag
whole
lung
partial
lung
imag
combin
use
bzx
analyz
softwar
keyenc
percentag
whole
lung
compos
hypercellular
area
associ
infiltr
inflammatori
cell
determin
use
bzx
analyz
softwar
describ
previous
human
alveolar
type
ii
epitheli
cell
carcinoma
cell
obtain
atcc
cell
cultur
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
gentamycin
per
ml
cell
passag
everi
day
hour
starvat
cell
treat
ng
human
recombin
per
ml
hour
wash
three
time
pb
cultur
fresh
serumfre
medium
hour
indic
time
point
cell
medium
collect
assess
role
cycl
cell
human
recombin
ngml
serumfre
medium
pretreat
ng
antihuman
monoclon
antibodi
r
system
per
ml
neutral
pb
minut
reaction
mixtur
ad
cell
cell
cultur
hour
stimul
cell
wash
three
time
pb
cultur
fresh
serumfre
medium
addit
hour
mrna
level
trypsin
measur
freshli
isol
lung
homogen
volum
pb
centrifug
minut
supernat
isol
lung
extract
media
cell
cultur
subject
elisa
analysi
level
trypsin
measur
use
elisa
kit
r
system
accord
respect
protocol
provid
manufactur
total
rna
cell
isol
use
rneasi
mini
kit
qiagen
hilden
germani
use
protocol
suppli
manufactur
cdna
synthes
use
oligonucleotid
primer
superscript
iii
rt
gibco
brl
grand
island
ny
realtim
rtpcr
use
measur
express
human
gene
access
number
trypsin
access
number
access
number
access
number
access
number
access
number
access
number
follow
primer
use
studi
forward
revers
forward
revers
forward
revers
forward
ggcaggtgaggagagtttga
revers
forward
revers
forward
revers
forward
revers
sybr
green
pcr
kit
roch
diagnost
mannheim
germani
abi
system
appli
biosystem
foster
citi
ca
use
quantifi
gene
reaction
condit
set
minut
follow
cycl
denatur
anneal
extens
rel
unit
calcul
standard
curv
normal
human
data
express
mean
standard
deviat
sd
least
three
replic
unless
state
otherwis
differ
group
examin
statist
signific
student
ttest
pvalu
less
consid
statist
signific
mice
infect
influenza
viru
studi
mode
upregul
proinflammatori
cytokin
ectop
trypsin
lung
earli
phase
infect
base
surviv
rate
chang
bodi
weight
variou
dose
infect
fig
chose
pfu
infect
dose
subsequ
experi
design
measur
chang
cytokin
trypsin
lung
level
increas
significantli
day
postinfect
gradual
decreas
afterward
meanwhil
level
trypsin
also
increas
significantli
day
postinfect
level
continu
persist
high
day
although
high
level
return
rapidli
baselin
infect
day
fig
interestingli
infect
mice
particularli
infect
pfu
show
sign
sick
eg
inact
ruffl
fur
labor
respir
bodi
weight
loss
infect
day
coincid
rise
proinflammatori
cytokin
trypsin
level
figur
show
doserespons
profil
effect
viru
infect
upregul
trypsin
lung
day
postinfect
result
indic
upregul
trypsin
correl
close
viral
dosag
clarifi
role
cytokin
host
cellular
respons
infect
analyz
effect
intraperiton
administr
alon
combin
andor
level
ectop
trypsin
proinflammatori
cytokin
day
posttreat
measur
chang
bodi
weight
anim
treat
alon
combin
andor
becam
sick
lost
weight
manner
similar
observ
mice
infect
pfu
howev
mice
treat
andor
show
detect
symptom
visibl
bodi
weight
loss
fig
find
suggest
seem
play
import
role
signal
cascad
pathogenesi
sever
influenza
viru
infect
experiment
condit
analyz
level
ectop
trypsin
proinflammatori
cytokin
lung
day
posttreat
fig
trypsin
level
significantli
increas
follow
administr
cytokin
tend
increas
follow
administr
combin
andor
particular
trypsin
level
induc
combin
plu
significantli
higher
induc
alon
salin
combin
cytokin
without
induc
trypsin
lung
result
suggest
indispens
trypsin
upregul
andor
play
costimulatori
role
effect
lung
increas
significantli
administr
variou
cytokin
combin
although
induc
alon
induc
significantli
cytokin
combin
includ
confirm
role
trypsin
upregul
lung
epitheli
cell
site
initi
viru
infect
human
alveolar
cell
treat
ng
per
ml
express
level
trypsin
cell
level
secret
medium
analyz
earliest
respons
challeng
secret
detect
hour
medium
follow
secret
hour
respect
signific
upregul
trypsin
mrna
detect
hour
cell
presenc
medium
fig
level
cytokin
trypsin
increas
continu
timedepend
manner
experi
isoform
human
major
trypsin
mrna
also
upregul
treatment
manner
similar
peak
hour
gradual
declin
within
hour
fig
find
indic
stimul
trypsin
isoform
gene
express
equal
lung
neutral
experi
perform
add
support
role
upregul
trypsin
proinflammatori
cytokin
cell
fig
ngml
initi
react
without
ng
antihuman
monoclon
antibodi
per
ml
neutral
serumfre
medium
minut
reaction
mixtur
ad
cell
cell
stimul
hour
wash
pb
cultur
addit
hour
serumfre
medium
incub
trypsin
mrna
level
cell
secret
level
medium
analyz
monoclon
antibodi
effect
abrog
upregul
trypsin
mrna
cell
reduc
level
seen
baselin
furthermor
neutral
also
prevent
rise
secret
protein
level
medium
verifi
role
cycl
multipl
organ
failur
infect
mice
antimous
neutral
polyclon
antibodi
administr
intraperiton
infect
pathohistolog
analysi
lung
conduct
day
postinfect
time
point
sever
lung
inflamm
lung
infect
mice
treat
salin
mous
igg
neg
control
inflammatori
cell
infiltr
accumul
bronchial
region
alveolar
wall
also
arteri
venou
area
result
abnorm
thicken
result
strong
stain
hematoxylin
fig
lung
even
exhibit
damag
alveolar
structur
lung
infect
mice
treat
neutral
polyclon
antibodi
howev
distribut
accumul
inflammatori
cell
lung
restrict
hypercellular
area
inflammatori
cell
infiltr
shown
red
hypocellular
area
shown
green
quantifi
whole
lung
area
fig
histolog
quantif
hypercellular
area
show
neutral
antibodi
treatment
significantli
suppress
develop
inflammatori
cell
aggreg
compar
salin
control
mous
igg
group
present
studi
made
sever
new
observ
among
proinflammatori
cytokin
induc
earli
phase
infect
play
key
role
trypsin
upregul
mous
lung
human
alveolar
cell
combin
andor
effect
upregul
trypsin
mous
lung
combin
cytokin
without
upregul
trypsin
mrna
equal
cell
presenc
antibodi
neutral
effici
suppress
upregul
proinflammatori
cytokin
trypsin
cell
also
suppress
develop
inflammatori
cell
aggreg
lung
infect
mice
report
previous
influenza
viru
infect
result
signific
increas
level
viral
hemagglutinin
process
proteas
ectop
trypsin
viral
replic
lung
host
anim
upregul
trypsin
induc
mobil
via
activ
follow
loss
intracellular
tight
junction
protein
zonula
result
vascular
hyperperm
multipl
organ
failur
furthermor
inhibitor
nuclear
factorkappa
b
activ
protein
effect
suppress
upregul
proinflammatori
cytokin
ectop
trypsin
improv
surviv
rate
infect
mice
base
result
propos
influenza
cycl
hypothesi
one
mechan
trypsin
upregul
vascular
dysfunct
multipl
organ
failur
cytokin
storm
sever
influenza
studi
interest
identifi
major
proinflammatori
cytokin
switch
trypsin
upregul
sever
influenza
viru
infect
identifi
key
cytokin
capabl
induc
trypsin
mous
lung
human
alveolar
cell
earli
phase
infect
use
four
experi
provid
support
result
first
found
intraperiton
inject
mixtur
proinflammatori
cytokin
upregul
ectop
trypsin
lung
cytokin
mixtur
lack
fig
second
incub
cell
presenc
stimul
secret
initi
follow
secret
final
upregul
trypsin
mrna
presenc
cultur
medium
fig
third
neutral
monoclon
antibodi
almost
complet
suppress
induct
vitro
fig
lastli
intraperiton
administr
neutral
polyclon
antibodi
effici
suppress
develop
inflammatori
cell
aggreg
lung
infect
mous
fig
effect
cytokin
synerg
report
variou
host
cellular
respons
synergist
effect
inflammatori
stress
mediat
chronic
lung
inflamm
viral
infect
report
particular
interact
mani
type
inflamm
mechan
synerg
studi
extens
result
add
support
find
confirm
upregul
trypsin
presenc
andor
report
previous
inhibitor
effect
suppress
upregul
proinflammatori
cytokin
ectop
trypsin
viral
replic
endotheli
dysfunct
result
signific
improv
surviv
infect
mice
transcript
factor
activ
signal
mitogenactiv
protein
kinas
mapk
pathway
shown
previou
studi
previou
studi
includ
support
present
find
role
trypsin
upregul
combin
andor
also
role
trypsin
induct
variou
signal
transduct
multipl
organ
failur
pronounc
suppress
effect
antibodi
effect
also
confirm
crucial
role
present
studi
indic
key
role
trypsin
upregul
earli
phase
influenza
viru
infect
mous
lung
figur
illustr
hypothesi
role
influenza
cycl
synergist
interact
andor
indic
arrow
direct
base
result
data
report
influenza
viru
infect
upregul
proinflammatori
cytokin
follow
synergist
interact
sinc
upregul
trypsin
effici
convert
prommp
activ
mmp
induct
trypsin
activ
mmp
synergist
degrad
vascular
basement
membran
extracellular
matrix
result
tissu
damag
edema
multipl
organ
failur
addit
upregul
trypsin
turn
provok
cytokin
releas
cellular
fluid
imbal
loss
intracellular
tight
junction
protein
zonula
via
activ
trypsinbas
cascad
result
vascular
hyperperm
multipl
organ
failur
sever
influenza
mani
studi
provid
evid
therapeut
effect
control
balanc
within
certain
level
variou
diseas
block
receptor
neutral
antibodi
vivo
experi
use
neutral
antibodi
also
demonstr
similar
outcom
addit
find
regard
hypothesi
illustr
figur
highlight
import
effect
restrain
avoid
trypsinmedi
diseas
aggrav
moreov
studi
focus
direct
synerg
effect
proinflammatori
cytokin
trypsin
upregul
need
strengthen
propos
hypothesi
addit
sever
hemagglutinin
process
proteas
human
airway
epithelium
trypsin
hat
play
role
influenza
viru
multipl
deni
possibl
upregul
proinflammatori
cytokin
infect
also
induc
process
proteas
therefor
studi
effect
inflammatori
cytokin
includ
hemagglutinin
process
proteas
need
understand
pathogenesi
multipl
organ
failur
sever
influenza
